Daniel Spiegelman
2012
In 2012, Daniel Spiegelman earned a total compensation of $8.9M as Executive Vice President, Chief Financial Officer at BioMarin Pharmaceutical.
Compensation breakdown
| Bonus | $350,000 |
|---|---|
| Non-Equity Incentive Plan | $237,600 |
| Option Awards | $2,186,250 |
| Salary | $250,462 |
| Stock Awards | $5,889,980 |
| Other | $4,000 |
| Total | $8,918,292 |
Spiegelman received $5.9M in stock awards, accounting for 66% of the total pay in 2012.
Spiegelman also received $350K in bonus, $237.6K in non-equity incentive plan, $2.2M in option awards, $250.5K in salary and $4K in other compensation.
Rankings
In 2012, Daniel Spiegelman's compensation ranked 510th out of 11,487 executives tracked by ExecPay. In other words, Spiegelman earned more than 95.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 510 out of 11,487 | 96th |
Division Manufacturing | 188 out of 4,252 | 96th |
Major group Chemicals And Allied Products | 39 out of 1,200 | 97th |
Industry group Drugs | 21 out of 922 | 98th |
Industry Pharmaceutical Preparations | 18 out of 697 | 97th |
Source: SEC filing on April 23, 2015.
Spiegelman's colleagues
We found four more compensation records of executives who worked with Daniel Spiegelman at BioMarin Pharmaceutical in 2012.
2012
Jean-Jacques Bienaim
BioMarin Pharmaceutical
Chief Executive Officer
2012
Henry Fuchs
BioMarin Pharmaceutical
Chief Medical Officer
2012
Jeff Ajer
BioMarin Pharmaceutical
Senior Vice President, Chief Commercial Officer
2012
Robert Baffi
BioMarin Pharmaceutical